Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)

NCT00959283 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT00959283
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00959283 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Lead sponsor
Children's Oncology Group
Phase
Observational
Overall status
Completed
Start date
February 23, 2009
Completion date
September 30, 2023
Enrollment
180 (actual)
Sites
189

Conditions

As the registry lists them; a condition with its own page is linked.

myeloid proliferations associated with down syndrome